|
|
|
ÀüÁÖ°æ ( Jeon Ju-Kyung ) - ¼¿ï¾Æ»êº´¿ø °£È£ºÎ
±èÁ¤Çý ( Kim Jeong-Hye ) - ¿ï»ê´ëÇб³ ÀÓ»óÀü¹®°£È£ÇÐ
|
|
Abstract
|
|
|
|
Purpose: The purpose of this study was to investigate the perception and satisfaction of cancer patients participating in clinical trials of anticancer drugs and the factors affecting their satisfaction.
Methods: The participants were cancer patients who participated in more than two cycles of clinical trials at a tertiary hospital in Seoul, Korea. Questionnaires were used to assess the perception and satisfaction of clinical trials of anticancer drugs.
Results: A total of 106 patients participated. The average perception and satisfaction regarding clinical trials among patients on a 5 point scale was 3.99¡¾0.45 and 4.09¡¾0.55 respectively. There was a significant difference in the correlation among participants' perception and their satisfaction (r =.67, p<.001). Regression analysis revealed that satisfaction was explained by, perception of clinical trials (¥â =.67, p<.001), participation period 30~59 days (¥â =.21, p=.009), and participation period over 60 days (¥â=.20, p=.013). These variables explained 48.7% of the variance of clinical trial satisfaction.
Conclusion: The results of this study suggest that changes in perceptions of clinical trials are needed to improve satisfaction of anticancer drug clinical trials. This can be used as a basis for improving the quality of clinical trials and education programs for cancer patients participating in clinical trials.
|
|
KeyWords
|
|
¾Ï, ÀÓ»ó½ÃÇè, ÀνÄ, ¸¸Á·µµ
Neoplasms, Clinical trial, Perception, Personal satisfaction
|
|
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
|
|
|
|
µîÀçÀú³Î Á¤º¸
|
|
|
|
|
|